Trials / Completed
CompletedNCT05655416
Treatment of Great Saphenous Vein Varicosities
Endovenous Chemical Ablation and Trendlenburg Operation for the Treatment of Great Saphenous Vein Varicosities
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Al-Azhar University · Academic / Other
- Sex
- —
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Venous insufficiency at lower extremities may result in clinical problems from cosmetic issues to ulcerations. When the frequency of venous insufficiency and its related problems are considered besides their diversity, it is encountered as a public health issue. This pathology is reported to affect 40% of women and 20% of men.1 Patients with varicose veins may complain of unsightly appearance, aching, heaviness, pruritus, and early fatigue of the affected leg. These symptoms worsen with prolonged standing and sitting and are relieved by elevation of the leg above the level of the heart. Also, mild edema is often present. More severe signs include thrombophlebitis, hyperpigmentation, lipodermatosclerosis, ulceration, and bleeding
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Endovenous chemical ablation with Trendelenburg's operation (eCAT) | Endovenous chemical ablation with trendelenburg's operation (e CAT) is a method for the treatment of varicose veins |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2021-04-01
- Completion
- 2021-04-05
- First posted
- 2022-12-19
- Last updated
- 2022-12-19
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05655416. Inclusion in this directory is not an endorsement.